Cervical cancer in Asian countries: epidemiology, risk factors and challenges
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20251429Keywords:
Cervical cancer, HPV vaccination, Screening, Asia, EpidemiologyAbstract
Cervical cancer is one of the leading causes for cancer mortality in women worldwide especially in Asian region where, preventive strategies are underdeveloped, particularly in low-and middle-income countries (LMICs). The global cervical cancer burden and characteristics vary significantly, particularly between high-income (HICs) and LMICs. To obtain a systematic review of 20 peer-reviewed newspaper articles published within the range from 2010 to 2023, accessed through PubMed, Scopus and Google Scholar. Studies related to incidence, mortality, preventive measures and healthcare disparity in Asian countries were included. Findings from the review demonstrate that cervical cancer is inordinate burdened in South-Central Asia, with nearly 48% of the region's estimated cases occurring between India and Bangladesh. The screening coverage is a cause for concern, with only 33% of women in India and 7.5% of women in Bangladesh getting screened regularly. In stark contrast, HPV vaccination coverage is below 30% in most LMICs with over 70% in Japan and South Korea. Low levels of healthcare infrastructure, late-stage diagnoses, and cultural barriers to vaccine uptake represent some of these key challenges. Effective HPV vaccination and screening programs can prevent cervical cancer (CC) cases and deaths, but the availability and coverage of these interventions in Asian LMICs are uncertain. Better prevention and treatment can be achieved through improved healthcare infrastructure, but first cultural barriers need to be overcome.
Metrics
References
Gothwal M, Singh P, Elhence P, Yadav G, Sharma C, Samriya N. Spectrum of abnormal cervical lesions and its cytohistological correlation: a study from an institute of national importance of western Rajasthan. Maedica. 2022;17(3):636. DOI: https://doi.org/10.26574/maedica.2022.17.3.636
Aoki ES, Yin R, Li K, Bhatla N, Singhal S, Ocviyanti D, et al. National screening programs for cervical cancer in Asian countries. J Gynecol Oncol. 2020;31(3):e55. DOI: https://doi.org/10.3802/jgo.2020.31.e55
Aktar S, Ali MS. Economic Burden of Illness of the Cervical Cancer Treatment Protocol in Bangladesh. J Cancer Therapy. 2024;15(10):346-61. DOI: https://doi.org/10.4236/jct.2024.1510033
Rajappa S, Singh M, Uehara R, Schachterle SE, Setia S. Cancer incidence and mortality trends in Asia based on regions and human development index levels: an analysis from GLOBOCAN 2020. Curr Med Res Opinion. 2023;39(8):1127-37. DOI: https://doi.org/10.1080/03007995.2023.2231761
Obeagu EI, Byukusenge C, Obeagu GU. Cervical Cancer: a review on young women. Eurasian Experiment J Biological Sci. 2023;4(1):92-6.
Wang SM, Qiao YL. Implementation of cervical cancer screening and prevention in China-challenges and reality. Japanese J Clin Oncol. 2015;45(1):7-11. DOI: https://doi.org/10.1093/jjco/hyu188
Mark Z. Morphologic Changes and Expression of Epithelial to Mesenchymal Transition (EMT) and Cervical Intraepithelial Neoplasia (CIN)-Related Markers with Activation of Receptor Tyrosine Kinases and Regulation of TGFB in Human Papillomavirus-Positive Cervical Epithelial Cells Exposed to Cigarette Smoke Condensate (Doctoral dissertation, Meharry Medical College). 2024.
Cao W, Qin K, Li F, Chen W. Socioeconomic inequalities in cancer incidence and mortality: An analysis of GLOBOCAN 2022. Chinese Med J. 2024;137(12):1407-13. DOI: https://doi.org/10.1097/CM9.0000000000003140
Shahida SM, Chowdhury M, Shajahan F, Rifat JA, Lubaba AS, Shamsuzzaman SM, et al. Distribution of High-Risk Human Papillomavirus Genotypes among Women with Colposcopic Diagnosis of Cervical Intraepithelial Neoplasia in Bangladesh. J Cancer Therapy. 2023;14(6):277-90. DOI: https://doi.org/10.4236/jct.2023.146023
Bal MS. Study of pap smears for cervical cancer screening and its correlation with cervical biopsy in Himachali women. Int J Life Sci Biotechnol Pharma Res. 2023;12(2):1612-21.
Ng CJ, Teo CH, Abdullah N, Tan WP, Tan HM. Relationships between cancer pattern, country income and geographical region in Asia. BMC Cancer. 2015;15:1-9. DOI: https://doi.org/10.1186/s12885-015-1615-0
Salehiniya H, Momenimovahed S, Allahqoli L, Momenimovahed Z, Alkatout I. Factors related to cervical cancer screening among Asian women. Europ Rev Med Pharmacological Sci. 2021;25(19):6109-22.
Jahan M, Islam T, Sultana S, Pervin M, Tabassum S. Distribution of high-risk Human Papilloma Virus genotypes among cervical cancer patients in a tertiary level hospital in Bangladesh: High risk Human Papilloma Virus genotypes. Bangladesh Med Res Council Bull. 2019;45(2):86-92. DOI: https://doi.org/10.3329/bmrcb.v45i2.42536
Jankovic S, Zivkovic Zaric R, Krasic K, Opancina V, Nedovic N, Zivkovic Radojevic M. New instrument for measuring quality of life in patients with cervical cancer. Health Care Women Int. 2021;42(7-9):1118-32. DOI: https://doi.org/10.1080/07399332.2021.1878174
Spayne J, Hesketh T. Estimate of global human papillomavirus vaccination coverage: analysis of country-level indicators. BMJ Open. 2021;11(9): e052016. DOI: https://doi.org/10.1136/bmjopen-2021-052016
Dykens JA, Smith JS, Demment M, Marshall E, Schuh T, Peters K, et al. Evaluating the implementation of cervical cancer screening programs in low-resource settings globally: a systematized review. Cancer Causes Control. 2020;31:417-29. DOI: https://doi.org/10.1007/s10552-020-01290-4
Lohiya A, Daniel RA, Kumar D, Varghese C, Rath RS, Abdulkader RS, et al. Effectiveness of visual inspection with acetic acid (VIA) screening on cervical cancer mortality and incidence-A systematic review and meta-analysis. Asian Pacific journal of cancer prevention: APJCP. 2022;23(2):399. DOI: https://doi.org/10.31557/APJCP.2022.23.2.399
Onyoh EF, Hsu WF, Chang LC, Lee YC, Wu MS, Chiu HM. The rise of colorectal cancer in Asia: epidemiology, screening, and management. Curr Gastroenterol Rep. 2019;21:1-0. DOI: https://doi.org/10.1007/s11894-019-0703-8
Canfell K, Kim JJ, Brisson M, Keane A, Simms KT, Caruana M, et al. Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries. The Lancet. 2020;395(10224):591-603. DOI: https://doi.org/10.1016/S0140-6736(20)30157-4
Xia C, Li S, Long T, Chen Z, Chan PK, Boon SS. Current updates on cancer-causing types of human papillomaviruses (HPVs) in East, Southeast, and South Asia. Cancers. 2021;13(11):2691. DOI: https://doi.org/10.3390/cancers13112691
Lee M, Gerend MA, Whittington KD, Collins SK, McKinney SL, Franca MC, et al. Factors associated with HPV-associated sexual risk behaviors among sexually active college students. J Behavioral Med. 2024;47(2):334-41. DOI: https://doi.org/10.1007/s10865-023-00463-1
Zhou D, Xue J, Sun Y, Zhu L, Zhao M, Cui M, et al. Patterns of single and multiple HPV infections in female: A systematic review and meta-analysis. Heliyon. 2024;10:17. DOI: https://doi.org/10.1016/j.heliyon.2024.e35736
Robles C, Bruni L, Acera A, Riera JC, Prats L, Poljak M, et al. Determinants of human papillomavirus vaccine uptake by adult women attending cervical cancer screening in 9 European countries. Am J Prevent Med. 2021;60(4):478-87. DOI: https://doi.org/10.1016/j.amepre.2020.08.032
Okunade KS. Human papillomavirus and cervical cancer. J Obstetr Gynaecol. 2020;40(5):602-8. DOI: https://doi.org/10.1080/01443615.2019.1634030
Brisson M, Kim JJ, Canfell K, Drolet M, Gingras G, Burger EA, et al. Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries. The Lancet. 2020;395(10224):575-90. DOI: https://doi.org/10.1016/S0140-6736(20)30068-4
Yurtçu E, Doğan RA, Karaaslan B, Mutlu S. Relationship between awareness of cervical cancer and HPV infection and attitudes towards HPV vaccine among women aged 15-49 years: a cross-sectional study. Sao Paulo Med J. 2022;140(3):349-55. DOI: https://doi.org/10.1590/1516-3180.2021.0145.27072021
Langa N, Bhatta T, Amuta A. Intersecting upstream factors: Inequities in cervical cancer screening in Malawi. Women's Reproductive Health. 2024;11(2):255-72. DOI: https://doi.org/10.1080/23293691.2023.2229308
de Sanjose S, Tsu VD. Prevention of cervical and breast cancer mortality in low-and middle-income countries: a window of opportunity. Int J Women's Health. 2019;11:381-6. DOI: https://doi.org/10.2147/IJWH.S197115
Mamsau N, Philippe A. Cancer prevention: cervical cancer. eCancerMedicalScience. 2019;13:952. DOI: https://doi.org/10.3332/ecancer.2019.950
Datta P, Bhatla N, Dar L, Patro AR, Gulati A, Kriplani A, et al. Prevalence of human papillomavirus infection among young women in North India. Cancer Epidemiol. 2010;34(2):157-61. DOI: https://doi.org/10.1016/j.canep.2009.12.016
Fidler MM, Soerjomataram I, Bray F. A global view on cancer incidence and national levels of the human development index. Int J Cancer. 2016;139(11):2436-46. DOI: https://doi.org/10.1002/ijc.30382
Simms KT, Steinberg J, Caruana M, Smith MA, Lew JB, Soerjomataram I, et al. Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020–99: a modelling study. The lancet Oncol. 2019;20(3):394-407. DOI: https://doi.org/10.1016/S1470-2045(18)30836-2
Parvez MH, Moula SG, Islam MM, Badruddoza AS, Ali MI. Impact of Surgeon Experience on Outcomes in Prostate Cancer Surgery; A Study of Learning Curves and Best Practices. Asia Pacific J Cancer Res. 2024;1(1):23-31. DOI: https://doi.org/10.70818/apjcr.2024.v01i01.06
Islam MS, Abdullah KS, Sadat CM, Islam MI. Surgical Innovations and Outcomes in the Management of Rectal Cancer: A Departmental Study on Advanced Techniques and Postoperative Care. Asia Pacific J Cancer Res. 2024;1(1):14-22. DOI: https://doi.org/10.70818/apjcr.2024.v01i01.05
Mishra GA, Pimple SA, Gupta SD. Evaluation of cytology as secondary triage in visual inspection after application of 4% acetic acid-based cervical cancer screening program. South Asian J Cancer. 2019;8(02):102-7. DOI: https://doi.org/10.4103/sajc.sajc_50_18
Ezebialu CU, Ezebialu IU, Ezeifeka GO, Nwobu RA, Okani CO, Chukwubuike CM. Prevalence of Cervical Human Pappillomavirus Infection in Awka, Nigeria. J Biosci Med. 2020;8(3):37-47. DOI: https://doi.org/10.4236/jbm.2020.83005
Priyadharisini J, Bharathi U, Pari P. Cytomorphological Spectrum of Cervical Pap Smear Reports Using the 2014 Bethesda System for Reporting Cervical Cytology: A Two Year Study in A Tertiary Care Hospital AT Puducherry, India. Int J Health Sci. 2014;6(S3):5482-90. DOI: https://doi.org/10.53730/ijhs.v6nS3.7152
Kadian L, Gulshan G, Sharma S, Kumari I, Yadav C, Nanda S, Yadav R. A study on knowledge and awareness of cervical cancer among females of rural and urban areas of Haryana, North India. J Cancer Educat. 2021;36(4):844-9. DOI: https://doi.org/10.1007/s13187-020-01712-6
Kaur R, Kant S, Shalli RS. A Retrospective Analysis of Cervical Cytology Using Pap Smear among Symptomatic Women Attending Gynaecology OPD in a Secondary Care Hospital in Northern India. Epidem Int. 2023;8(2):7-11. DOI: https://doi.org/10.24321/2455.7048.202308
Khurshid Z, Abdullahi KO, Parveen K, Khan S. Factors Contributing to Cervical Cancer Among Women: A Systematic Review and Meta-Analysis: Cervical Cancer Among Women. Pak BioMed J. 2022;31:72-6. DOI: https://doi.org/10.54393/pbmj.v5i8.675
Bhusal CL, Manandhar S, Singh M, Shah A, Neupane S, Karmacharya D, Cuschieri K, Cubie H, Gilbert DC, Dixit SM. Evidence of HPV subtypes linked with cervical cancer in Nepal. WHO South-East Asia J Public Health. 2012;1(4):441-5. DOI: https://doi.org/10.4103/2224-3151.207046
Soofi M, Karami-Matin B, Najafi F, Naghshbandi P, Soltani S. Decomposing socioeconomic disparity in the utilization of screening mammography: A cross-sectional analysis from the RaNCD cohort study. Health Care Women Int. 2023;44(9):1092-105. DOI: https://doi.org/10.1080/07399332.2021.2009833
Zhang S, Xu H, Zhang L, Qiao Y. Cervical cancer: Epidemiology, risk factors and screening. Chin J Cancer Res. 2020;32(6):720. DOI: https://doi.org/10.21147/j.issn.1000-9604.2020.06.05
Zhao S, Huang L, Basu P, Domingo EJ, Supakarapongkul W, Ling WY, et al. Cervical cancer burden, status of implementation and challenges of cervical cancer screening in Association of Southeast Asian Nations (ASEAN) countries. Cancer Letters. 2022;525:22-32. DOI: https://doi.org/10.1016/j.canlet.2021.10.036
Agustiansyah P, Sanif R, Nurmaini S. Epidemiology and risk factors for cervical cancer. Bioscientia Medicina: J Biomed Translational Res. 2021;5(7):624-31. DOI: https://doi.org/10.32539/bsm.v5i7.326
Downloads
Published
How to Cite
Issue
Section
